Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2012 Jun 29;11(9):2054–2061. doi: 10.1158/1535-7163.MCT-12-0221

Figure 2.

Figure 2

Discovered and replicated positive correlation between miR-193b* expression and platinum sensitivity. A, B) The relationship between miR-193b* expression on the one hand and carboplatin and cisplatin IC50 on the other in the discovery-phase CEU samples, respectively; C, D) The relationship between miR-193b* expression on the one hand and carboplatin and cisplatin IC50 on the other in the replication CEU samples, respectively. Exiqon arrays were used to obtain miRNA expression data in the discovery-phase samples while real-time PCR method was used to quantify miRNA expression in the replication samples.